{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:51:08Z","timestamp":1794649868589,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Influenza may trigger complications, particularly in at-risk groups, potentially leading to hospitalization or death. However, due to lack of routine testing, influenza cases are infrequently coded with influenza-specific diagnosis. Statistical models using influenza activity as an explanatory variable can be used to estimate annual hospitalizations and deaths associated with influenza. Our study aimed to estimate the clinical and economic burden of severe influenza in Spain, considering such models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study comprised ten epidemic seasons (2008\/2009\u20132017\/2018) and used two approaches: (i) a direct method of estimating the seasonal influenza hospitalization, based on the number of National Health Service hospitalizations with influenza-specific International Classification of Diseases (ICD) codes (ICD-9: 487\u2013488; ICD-10: J09-J11), as primary or secondary diagnosis; (ii) an indirect method of estimating excess hospitalizations and deaths using broader groups of ICD codes in time-series models, computed for six age groups and four groups of diagnoses: pneumonia or influenza (ICD-9: 480\u2013488, 517.1; ICD-10: J09\u2013J18), respiratory (ICD-9: 460\u2013519; ICD-10: J00\u2013J99), respiratory or cardiovascular (C&amp;R, ICD-9: 390\u2013459, 460\u2013519; ICD-10: I00\u2013I99, J00\u2013J99), and all-cause. Means, excluding the H1N1pdm09 pandemic (2009\/2010), are reported in this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean number of hospitalizations with a diagnosis of influenza per season was 13,063, corresponding to 28.1 cases per 100,000 people. The mean direct annual cost of these hospitalizations was \u20ac45.7 million, of which 65.7% was generated by patients with comorbidities. Mean annual influenza-associated C&amp;R hospitalizations were estimated at 34,894 (min: 16,546; max: 52,861), corresponding to 75.0 cases per 100,000 (95% confidence interval [CI]: 63.3\u201386.3) for all ages and 335.3 (95% CI: 293.2\u2013377.5) in patients aged\u2009\u2265\u200965\u00a0years. We estimate 3.8 influenza-associated excess C&amp;R hospitalizations for each hospitalization coded with an influenza-specific diagnosis in patients aged\u2009\u2265\u200965\u00a0years. The mean direct annual cost of the estimated excess C&amp;R hospitalizations was \u20ac142.9 million for all ages and \u20ac115.9 million for patients aged\u2009\u2265\u200965\u00a0years. Mean annual influenza-associated all-cause mortality per 100,000 people was estimated at 27.7 for all ages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results suggest a relevant under-detected burden of influenza mostly in the elderly population, but not neglectable in younger people.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08015-3","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:04:06Z","timestamp":1675782246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008\u20132018"],"prefix":"10.1186","volume":"23","author":[{"given":"T.","family":"Pumarola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"D\u00edez-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Martin\u00f3n-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Redondo Marg\u00fcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Ortiz","family":"de Lejarazu Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bizouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"L\u00f3pez-Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bricout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gil-de-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"issue":"1","key":"8015_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","volume":"7","author":"CE Troeger","year":"2019","unstructured":"Troeger CE, Blacker BF, Khalil IA, Zimsen SRM, Albertson SB, Abate D, Abdela J, Adhikari TB, Aghayan SA, Agrawal S, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69\u201389.","journal-title":"Lancet Respir Med"},{"issue":"10095","key":"8015_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules C, Subbarao K. Influenza. The Lancet. 2017;390(10095):697\u2013708.","journal-title":"The Lancet"},{"issue":"Suppl 1","key":"8015_CR3","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","volume":"39","author":"AE Macias","year":"2021","unstructured":"Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, Seet BT, Weinke T, Yu H. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39(Suppl 1):A6\u201314.","journal-title":"Vaccine"},{"key":"8015_CR4","unstructured":"Mondiale de la Sant\u00e9 O, Organization WH. Vaccines against influenza: WHO position paper\u2013May 2022\u2013Vaccins antigrippaux: note de synth\u00e8se de l\u2019OMS\u2013mai 2022. Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire 2022, 97(19):185\u2013208."},{"key":"8015_CR5","unstructured":"https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/vaccination."},{"key":"8015_CR6","unstructured":"MCSBS: Coberturas de vacunaci\u00f3n frente a gripe en \u226565 a\u00f1os, personas de 60\u201364 a\u00f1os, embarazadas y personal sanitario. Comunidades aut\u00f3nomas. Campa\u00f1a 2018\u20132019 (actualizaci\u00f3n). In. Edited by Direcci\u00f3n General de Salud P\u00fablica CeI, Subdirecci\u00f3n General de Promoci\u00f3n de la Salud y Vigilancia en Salud P\u00fablica; 2019."},{"key":"8015_CR7","unstructured":"MCSBS: Coberturas de vacunaci\u00f3n frente a gripe en \u226565 a\u00f1os, personas de 60\u201364 a\u00f1os, embarazadas y personal sanitario. Comunidades aut\u00f3nomas. Campa\u00f1a 2020\u20132021. In. Edited by Direcci\u00f3n General de Salud P\u00fablica CeI SGdPdlSyP; 2021."},{"key":"8015_CR8","unstructured":"MCSBS: Evoluci\u00f3n de cobertura de vacunaci\u00f3n antigripal en poblaci\u00f3n \u2265 65 a\u00f1os. Espa\u00f1a, temporadas 2008\u20132009 a 2017\u20132018 (actualizaci\u00f3n). Edited by Direcci\u00f3n General de Salud P\u00fablica CeI, Subdirecci\u00f3n General de Promoci\u00f3n de la Salud y Vigilancia en Salud P\u00fablica.; 2018"},{"key":"8015_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMp1300375","volume":"368","author":"J Bresee","year":"2013","unstructured":"Bresee J, Hayden F. Epidemic Influenza - Responding to the Expected but Unpredictable. N Engl J Med. 2013;368:89.","journal-title":"N Engl J Med"},{"key":"8015_CR10","unstructured":"Vaccine Effectiveness: How Well Do Flu Vaccines Work? https:\/\/www.cdc.gov\/flu\/vaccines-work\/vaccineeffect.htm"},{"issue":"1","key":"8015_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/irv.12501","volume":"12","author":"E Rodrigues","year":"2018","unstructured":"Rodrigues E, Machado A, Silva S, Nunes B. Excess pneumonia and influenza hospitalizations associated with influenza epidemics in Portugal from season 1998\/1999 to 2014\/2015. Influenza Other Respir Viruses. 2018;12(1):153\u201360.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"8015_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244746","volume":"16","author":"MA Hamilton","year":"2021","unstructured":"Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, Kustra R, Baral SD, Mishra S, Kwong JC. Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS ONE. 2021;16(1): e0244746.","journal-title":"PLoS ONE"},{"issue":"S2","key":"8015_CR13","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.2105\/AJPH.2008.151944","volume":"99","author":"WW Thompson","year":"2009","unstructured":"Thompson WW, Moore MR, Weintraub E, Cheng P-Y, Jin X, Bridges CB, Bresee JS, Shay DK. Estimating Influenza-Associated Deaths in the United States. Am J Public Health. 2009;99(S2):S225\u201330.","journal-title":"Am J Public Health"},{"issue":"1","key":"8015_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1186\/s12879-019-4308-5","volume":"19","author":"JM San-Rom\u00e1n-Montero","year":"2019","unstructured":"San-Rom\u00e1n-Montero JM, Gil Prieto R, Gallardo Pino C, Hinojosa Mena J, Zapatero Gaviria A. Gil de Miguel A: Inpatient hospital fatality related to coding (ICD-9-CM) of the influenza diagnosis in Spain (2009\u20132015). BMC Infect Dis. 2019;19(1):700\u2013700.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8015_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.medcli.2018.11.014","volume":"153","author":"A P\u00e9rez-Rubio","year":"2019","unstructured":"P\u00e9rez-Rubio A, Platero L, Eiros Bouza JM. Gripe estacional en Espa\u00f1a: carga cl\u00ednica y econ\u00f3mica y programas de vacunaci\u00f3n. Med Clin. 2019;153(1):16\u201327.","journal-title":"Med Clin"},{"issue":"2","key":"8015_CR16","doi-asserted-by":"publisher","first-page":"e31696","DOI":"10.1371\/journal.pone.0031696","volume":"7","author":"M Galante","year":"2012","unstructured":"Galante M, Garin O, Sicuri E, Cots F, Garc\u00eda-Alt\u00e9s A, Ferrer M, Dominguez \u00c0, Alonso J. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS ONE. 2012;7(2):e31696\u2013e31696.","journal-title":"PLoS ONE"},{"issue":"5","key":"8015_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1157\/13092984","volume":"38","author":"X Badia Llach","year":"2006","unstructured":"Badia Llach X, Roset Gamisans M, Franc\u00e9s Tudel JM, Alvarez Sanz C, Rubio Terr\u00e9s C. Study of flu costs. Aten Primaria. 2006;38(5):260\u20137.","journal-title":"Aten Primaria"},{"key":"8015_CR18","doi-asserted-by":"crossref","unstructured":"Albert\u00ed C, Orriols R, Manzanera R, Jard\u00ed J: Flu and other Acute Respiratory Infections in the Working Population. The Impact of Influenza A (H1N1) Epidemic. Archivos de Bronconeumolog\u00eda ((English Edition)) 2010, 46(12):634\u2013639.","DOI":"10.1016\/S1579-2129(10)70138-5"},{"issue":"1","key":"8015_CR19","doi-asserted-by":"publisher","first-page":"e0146620","DOI":"10.1371\/journal.pone.0146620","volume":"11","author":"M Soto","year":"2016","unstructured":"Soto M, Sampietro-Colom L, Vilella A, Pantoja E, Asenjo M, Arjona R, Hurtado JC, Trilla A, Alvarez-Mart\u00ednez MJ, Mira A, et al. Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients. PLoS ONE. 2016;11(1):e0146620\u2013e0146620.","journal-title":"PLoS ONE"},{"issue":"4","key":"8015_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s41669-022-00329-3","volume":"6","author":"\u00c1 Gil de Miguel","year":"2022","unstructured":"Gil de Miguel \u00c1, Eiros Bouza JM, Mart\u00ednez Alcorta LI, Callejo D, Mi\u00f1arro C, Vallejo-Aparicio LA, Garc\u00eda A, Tafalla M, Cambronero MDR, Rodr\u00edguez R, et al. Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain. Pharmacoeconomics. 2022;6(4):509\u201318.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"8015_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.gaceta.2015.01.011","volume":"29","author":"I Le\u00f3n-G\u00f3mez","year":"2015","unstructured":"Le\u00f3n-G\u00f3mez I, Delgado-Sanz C, Jim\u00e9nez-Jorge S, Flores V, Sim\u00f3n F, G\u00f3mez-Barroso D, Larrauri A, de Mateo OS. Excess mortality associated with influenza in Spain in winter 2012. Gac Sanit. 2015;29(4):258\u201365.","journal-title":"Gac Sanit"},{"issue":"4","key":"8015_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.gaceta.2011.09.033","volume":"26","author":"T L\u00f3pez-Cuadrado","year":"2012","unstructured":"L\u00f3pez-Cuadrado T, de Mateo S, Jim\u00e9nez-Jorge S, Savulescu C, Larrauri A. Influenza-related mortality in Spain, 1999\u20132005. Gac Sanit. 2012;26(4):325\u20139.","journal-title":"Gac Sanit"},{"issue":"1","key":"8015_CR23","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1186\/s12889-022-14732-2","volume":"22","author":"\u00c1 Gil-de-Miguel","year":"2022","unstructured":"Gil-de-Miguel \u00c1, Martin\u00f3n-Torres F, D\u00edez-Domingo J, de Lejarazu Leonardo RO, Pumarola T, Carmo M, Drago G, L\u00f3pez-Belmonte JL, Bricout H, de Courville C, et al. Clinical and economic burden of physician-diagnosed influenza in adults during the 2017\/2018 epidemic season in Spain. BMC Public Health. 2022;22(1):2369.","journal-title":"BMC Public Health"},{"issue":"1","key":"8015_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12879-022-07713-8","volume":"22","author":"F Froes","year":"2022","unstructured":"Froes F, Carmo M, Lopes H, Bizouard G, Gomes C, Martins M, Bricout H, de Courville C, de Sousa JC, Raba\u00e7al C, et al. Excess hospitalizations and mortality associated with seasonal influenza in Portugal, 2008\u20132018. BMC Infect Dis. 2022;22(1):726.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8015_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07745-0","volume":"22","author":"F Martin\u00f3n-Torres","year":"2022","unstructured":"Martin\u00f3n-Torres F, Carmo M, Platero L, Drago G, L\u00f3pez-Belmonte J, Bangert M, D\u00edez-Domingo J, Garc\u00e9s-S\u00e1nchez M. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study. BMC Infect Dis. 2022;22(1):1\u201315.","journal-title":"BMC Infect Dis"},{"key":"8015_CR26","doi-asserted-by":"crossref","unstructured":"Bandeira T, Carmo M, Lopes H, Gomes C, Martins M, Guzman C, Bangert M, Rodrigues F, Janu\u00e1rio G, Tom\u00e9 T. Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015\u20132018. Influenza and Other Respiratory Viruses 2022.","DOI":"10.1111\/irv.13066"},{"issue":"2","key":"8015_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/irv.12700","volume":"14","author":"CA Czaja","year":"2020","unstructured":"Czaja CA, Miller L, Colborn K, Cockburn MG, Alden N, Herlihy RK, Sim\u00f5es EAF. State-level estimates of excess hospitalizations and deaths associated with influenza. Influenza Other Respir Viruses. 2020;14(2):111\u201321.","journal-title":"Influenza Other Respir Viruses"},{"key":"8015_CR28","unstructured":"https:\/\/www.cdc.gov\/flu\/about\/burden\/how-cdc-estimates.htm#References."},{"issue":"8","key":"8015_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.rce.2013.02.015","volume":"213","author":"L Lindner","year":"2013","unstructured":"Lindner L, Garc\u00eda-S\u00e1nchez R, Alvarez C, Beteg\u00f3n L, Badia X. Hospitalizaciones por hipoglucemia grave en pacientes con diabetes mellitus en Espa\u00f1a. Rev Clin Esp. 2013;213(8):370\u20136.","journal-title":"Rev Clin Esp"},{"key":"8015_CR30","unstructured":"INE: Estad\u00edsticas de Defunciones seg\u00fan la Causa de Muerte, 2008 - 2018. In: Edited by Estad\u00edstica INd; 2020."},{"key":"8015_CR31","unstructured":"ScVGE. Tasas de incidencia semanal de gripe, temporadas 2007\u201308 a 2018\u201319. In: Edited by Epidemiol\u00f3gica. ScdVdlGeESRNdV; 2020."},{"key":"8015_CR32","unstructured":"Decision A. 253\/EC Laying Down Case Definitions for Reporting Communicable Diseases to the Community Network Under Decision No 2119\/98\/EC of the European Parliament and of the Council.In: Official Journal of the European Union 2012."},{"key":"8015_CR33","unstructured":"ISCIII. Gu\u00eda de procedimientos para la vigilancia de gripe en Espa\u00f1a, Octubre 2019. In: Edited by Microbiolog\u00eda GdVdGdCNdELdVRyGdCNd; 2019."},{"issue":"2","key":"8015_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2471\/BLT.17.194514","volume":"96","author":"J Fitzner","year":"2018","unstructured":"Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, Brown C, Clark S, Dueger E, Gross D. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96(2):122.","journal-title":"Bull World Health Organ"},{"key":"8015_CR35","unstructured":"INE. Poblaci\u00f3n residente por grupo de edad, a 1 enero de cada a\u00f1o, 2008\u20132019. In: Instituto Nacional de Estad\u00edstica; 2020."},{"issue":"2","key":"8015_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States. JAMA. 2003;289(2):179.","journal-title":"JAMA"},{"issue":"5682","key":"8015_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith DJ. Mapping the Antigenic and Genetic Evolution of Influenza Virus. Science. 2004;305(5682):371\u20136.","journal-title":"Science"},{"issue":"9","key":"8015_CR38","doi-asserted-by":"publisher","first-page":"e45051","DOI":"10.1371\/journal.pone.0045051","volume":"7","author":"M Lemaitre","year":"2012","unstructured":"Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A\/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A\/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051\u2013e45051.","journal-title":"PLoS ONE"},{"issue":"9","key":"8015_CR39","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1017\/S0950268811002238","volume":"140","author":"L Yang","year":"2011","unstructured":"Yang L, Chan KP, Cowling BJ, Chiu SS, Chan KH, Peiris JSM, Wong CM. Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect. 2011;140(9):1542\u201350.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"8015_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1134-282X(01)77392-7","volume":"16","author":"L Garc\u00eda-Eroles","year":"2001","unstructured":"Garc\u00eda-Eroles L, Illa C, Arias A, Casas M. Los Top 20 2000: objetivos, ventajas y limitaciones del m\u00e9todo. Rev Calid Asist. 2001;16(2):107\u201316.","journal-title":"Rev Calid Asist"},{"issue":"3","key":"8015_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10729-006-9089-x","volume":"9","author":"F S\u00e1nchez-Mart\u00ednez","year":"2006","unstructured":"S\u00e1nchez-Mart\u00ednez F, Abell\u00e1n-Perpi\u00f1\u00e1n JM, Mart\u00ednez-P\u00e9rez JE, Puig-Junoy J. Cost accounting and public reimbursement schemes in Spanish hospitals. Health Care Manag Sci. 2006;9(3):225\u201332.","journal-title":"Health Care Manag Sci"},{"issue":"4","key":"8015_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/irv.12966","volume":"16","author":"SSS Schmidt","year":"2022","unstructured":"Schmidt SSS, Iuliano AD, Vestergaard LS, Mazagatos-Ateca C, Larrauri A, Brauner JM, Olsen SJ, Nielsen J, Salomon JA, Krause TG. All-cause versus cause-specific excess deaths for estimating influenza-associated mortality in Denmark, Spain, and the United States. Influenza Other Respir Viruses. 2022;16(4):707\u201316.","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"8015_CR43","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.vaccine.2021.11.080","volume":"40","author":"J Paget","year":"2022","unstructured":"Paget J, Danielle Iuliano A, Taylor RJ, Simonsen L, Viboud C, Spreeuwenberg P. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project. Vaccine. 2022;40(9):1361\u20139.","journal-title":"Vaccine"},{"issue":"10127","key":"8015_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet (London, England). 2018;391(10127):1285\u2013300.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"8015_CR45","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.10.020430","volume":"10","author":"KM Roguski","year":"2020","unstructured":"Roguski KM, Rolfes MA, Reich JS, Owens Z, Patel N, Fitzner J, Cozza V, Lafond KE, Azziz-Baumgartner E, Iuliano AD. Variability in published rates of influenza-associated hospitalizations: A systematic review, 2007\u20132018. J Glob Health. 2020;10(2): 020430.","journal-title":"J Glob Health"},{"key":"8015_CR46","unstructured":"III IdSC. Informes de Vigilancia de la Gripe en Espa\u00f1a, temporadas 2008\u20132009 hasta la temporada 2017\u20132018. In: Edited by Espa\u00f1a SdVdlGe; 2008\u20132018."},{"issue":"2","key":"8015_CR47","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019;9(2): 020421.","journal-title":"J Glob Health"},{"issue":"2","key":"8015_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/ije\/dyab138","volume":"51","author":"VK Leung","year":"2022","unstructured":"Leung VK, Wong JY, Barnes R, Kelso J, Milne GJ, Blyth CC, Cowling BJ, Moore HC, Sullivan SG. Excess respiratory mortality and hospitalizations associated with influenza in Australia, 2007\u20132015. Int J Epidemiol. 2022;51(2):458\u201367.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"8015_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/irv.12564","volume":"12","author":"J Nielsen","year":"2018","unstructured":"Nielsen J, Krause TG, M\u00f8lbak K. Influenza-associated mortality determined from all-cause mortality, Denmark 2010\/11-2016\/17: The FluMOMO model. Influenza Other Respir Viruses. 2018;12(5):591\u2013604.","journal-title":"Influenza Other Respir Viruses"},{"key":"8015_CR50","unstructured":"Influenza Hospitalization Surveillance Network (FluSurv-NET). https:\/\/www.cdc.gov\/flu\/weekly\/influenza-hospitalization-surveillance.htm."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08015-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08015-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08015-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T15:52:07Z","timestamp":1706197927000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08015-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8015"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08015-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"3 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the ethical principles of the Declaration of Helsinki and the local regulation, including privacy laws. The protocol of the BARI study was validated by a panel of clinical experts, classified by the Agency of Medicines and Medical Devices (AEMPS) as an observational study and approved by the Ethics Committee of Hospital Clinic de Barcelona (HCB\/2020\/1132). Informed consent to participate was waived by the same ethics committee that approved the study (Ethics Committee of Hospital Clinic de Barcelona).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Drago G, L\u00f3pez-Belmonte JL, Bricout H, and de Courville C are the employees of Sanofi and may hold shares and\/or stock options in the company. Carmo M, Bizouard G are the employees of IQVIA. Gil-de-Miguel A and D\u00edez-Domingo J have received fees from Sanofi. Martin\u00f3n-Torres F received honoraria from GSK group of companies, Pfizer Inc, Sanofi, MSD, Seqirus, and Janssen for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Martin\u00f3n-Torres F has also acted as the principal investigator in randomized controlled trials of the above-mentioned companies as well as Ablynx, Gilead, Regeneron, Roche, Abbott, Novavax, and MedImmune, with honoraria paid to his institution. Ortiz de Lejarazu R received honoraria from AstraZeneca, GSK, MSD, Roche, Sanofi, and Seqirus for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Ortiz de Lejarazu R has been the Director of the National Influenza Centre, Valladolid, Spain, until 2019, without any salary for that position and has participated in regular commitments of influenza and other respiratory virus surveillance. Pumarola T received honoraria from Roche, Sanofi, Seegene, and Seqirus for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Redondo Marg\u00fcello E received honoraria from GSK group of companies, Pfizer Inc, Sanofi, and MSD, for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}